July 13, 2015

The Food and Drug Administration warns patients that prolonged use of NSAIDs could increase risk of heart attack or stroke. 

July 13, 2015

Otsuka Pharmaceutical and H. Lundbeck A/S announced Friday that their new medication Rexulti (brexpiprazole) had been approved by the Food and Drug Administration as an adjunctive treatment for major depressive disorder (MDD) and a treament for schizophrenia. 

July 1, 2015

Teva Pharmaceuticals announced the U.S.-wide availability of generic Aggrenox (aspirin and extended-release dipyridamole) capsules, which contain that can reduce the risk of stroke, on Wednesday.

June 24, 2015

Aurobindo Pharma Limited has announced that it has received final approval from the U.S. Food and Drug Administration for entacapone tablets USP, 200 mg, the generic equivalent to Comtan Tablets 200 mg.

June 23, 2015

Teva announced Monday that it had introduced its generic version of Focalin XR (dexmethylphenidate hydrochloride) extended-release capsules in a new 20-mg dosage strength. 

June 15, 2015

In the past 12 months ended April 19, Zyrtec (McNeil Consumer Healthcare) continues to dominate the allergy category with total retail sales of $332 million.

June 10, 2015

Despite high-profile efforts to implement abuse-deterrent labels and properties on brand-name opioids, advisory company Avalere Health’s latest research notes a key blind spot in the efforts — accessibility.

June 3, 2015

The Pepcid Tastemakers Restaurant Week will be featured in both New York and Chicago.

May 28, 2015

Camber Pharmaceuticals on Thursday announced that it had launched antipsychotic drug aripiprazole — a generic version of Abilify — in 2-, 5-, 10-, 15-, 20- and 30-mg dosage strength tablets. 

May 19, 2015

Pharmacy Quality Alliance has endorsed three new performance measures to assess the use of opioids. 

May 12, 2015

PharmaSmart was recognized as uniquely qualified among kiosks for use in the diagnosis and treatment of hypertension.

May 4, 2015

Epic Pharma has added two new generic drugs to its portfolio of products.

April 29, 2015

The Food and Drug Administration announced approval for the first generic versions of aripiprazole tablets.

April 29, 2015

Teva Pharmaceutical announced the launch of aripiprazole tablets in 2-, 5-, 10-, 15, 20- and 30-mg strengths in the United States.

April 22, 2015

If you were impressed by the recent switches of Nasacort Allergy 24HR, Nexium 24HR or Flonase — well-executed and model switches — well, you ain’t seen nothing yet.

April 7, 2015

A new indication for Boehringer Ingelheim Pharmaceuticals's Pradaxa may be on the horizon. 

March 31, 2015

The drug is Food and Drug Administration-approved to treat opioid-induced constipation in adults with chronic, non-cancer pain. 

March 31, 2015

Teva Pharmaceutical Industries announced the launch of generic Exforge (amlodipine and valsartan) tablets, which are indicated for the treatment of hypertension. 

 

March 11, 2015

Mylan launched its fentanyl transdermal system in 37.5-, 62.5- and 87.50-mcg/hr dosage strengths in the United States.

March 11, 2015

Mylan expanded its portfolio of generic products with the U.S. launch of buprenorphine hydrochloride sublingual tablets in 2-mg and 8-mg strengths, the generic version of Subutex from Reckitt Benckiser.

March 10, 2015

Actavis expanded its portfolio of topicals with the launch of a generic corticosteroid.

March 10, 2015

ANI Pharmaceuticals acquired the approved abbreviated new drug application for flecainide acetate tablets USP in 50-mg, 100-mg and 150-mg dosage strengths.

March 4, 2015

Almost half of all circular ads in support of a digestive remedy promote an antacid tablet. 

March 4, 2015

Drug Store News has partnered with Competitive Promotion Report and IRI to create a series of exclusive reports. This edition explores cold/allergy/sinus products in both the liquid/powder and tablets/packets segments.